SEC Form 4 · accession 0001179110-16-032096
Blueprint Medicines Corp · BPMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marion Dorsch
Officer — Chief Scientific Officer
Period of report
Nov 21, 2016
Accepted (ET)
Nov 23, 2016 · 5:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597264
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $37.11 | Nov 21, 2016 | A | 110,000 | A | — | Nov 21, 2026 | Common Stock | 110,000 | 110,000 | D |
Explanation of responses
- F1In accordance with the Reporting Person's employment agreement with the Issuer, this option was granted effective as of the first day of the Reporting Person's employment with the Issuer on November 21, 2016.
- F2This option vests with respect to 25% of the shares underlying the option on November 21, 2017 and as to an additional 1/48th of the shares underlying the option each month thereafter.